Sanofi seeks to prevent Praluent injunction

09-05-2017

Sanofi seeks to prevent Praluent injunction

hocus-focus / iStockphoto.com

Sanofi and Regeneron have filed the latest round of their appeal to the US Court of Appeals for the Federal Circuit in a bid to stop an injunction against Praluent.


Amgen, Sanofi, Regeneron, Federal Circuit, patent, injunction, permanent injunction

LSIPR